Mosaic ImmunoEngineering Inc.
CPMV · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $16 | $16 | $16 | $16 |
| G&A Expenses | $128 | $133 | $159 | $134 |
| SG&A Expenses | $128 | $133 | $159 | $134 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $144 | $149 | $175 | $150 |
| Operating Income | -$144 | -$149 | -$175 | -$150 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | -$21 | -$21 | -$7 | -$0 |
| Pre-Tax Income | -$165 | -$170 | -$181 | -$151 |
| Tax Expense | $0 | $2 | $0 | $2 |
| Net Income | -$165 | -$172 | -$181 | -$153 |
| % Margin | – | – | – | – |
| EPS | -0.023 | -0.024 | -0.025 | -0.021 |
| % Growth | 4.2% | 5.2% | -19% | – |
| EPS Diluted | -0.023 | -0.024 | -0.025 | -0.021 |
| Weighted Avg Shares Out | 7,236 | 7,236 | 7,236 | 7,242 |
| Weighted Avg Shares Out Dil | 7,236 | 7,236 | 7,236 | 7,242 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $21 | $21 | $21 | $21 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$144 | -$149 | -$161 | -$129 |
| % Margin | – | – | – | – |